Ahmet Dogan

76PUBLICATIONS
568CO-AUTHORS
Haematological tumoursModelling and simulationCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (76)

|Oct 02, 2026
Pembrolizumab-GVD in relapsed or refractory Hodgkin lymphoma: 5-year update of a multicenter phase 2 trial.

|Sep 28, 2026
An AI-powered self-driving microscope for low-cost acute leukemia detection.

|Jul 10, 2026
Clinical outcomes, patterns of relapse, and molecular landscape of advanced stage high-grade B-cell lymphoma.

|Jul 07, 2026
Concurrent administration of BCMA and GPRC5D CAR T cells for advanced multiple myeloma.

|Jun 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

|Jun 12, 2026
Genomic Features Do Not Account for Differences in Multiple Myeloma Risk by Ancestry.

Pageof 13

Frequent Collaborators

21 joint publications

Gilles Salles

14 joint publications

Andrew D Zelenetz

12 joint publications

Ola Landgren

12 joint publications

Santosha Vardhana